Essentra plc Director/PDMR Shareholding
Notification and public disclosure of transactions by persons discharging managerial responsibility
Further to the announcement earlier today relating to the vesting of share options, Scott Fawcett, Chief Executive Officer, and a Person Discharing Managerial Responsibility ("PDMR") under article 19 of the Market Abuse Regulation ("MAR"), has partially exercised share options to sell to cover, as set out below.
Following the transaction, the resultant holding held by Scott Fawcett in Essentra shares is 180,792 ordinary shares of 25 pence.
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||||||||||||||||||||||||||||||
| a)
| Name
| Scott Fawcett
| |||||||||||||||||||||||||||||||
| 2
| Reason for the notification Transfer and sale of shares, pursuant to the satisfaction of the performance conditions, awarded under the Company's Long Term Incentive Plan Part B grant of September 2017 ("LTIP"), and the Deferred Annual Share Bonus scheme ("DASB").
| ||||||||||||||||||||||||||||||||
| a)
| Position/status
| Chief Executive Officer | |||||||||||||||||||||||||||||||
| b)
| Initial notification /Amendment
| Initial | |||||||||||||||||||||||||||||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||||||||||||||||||||||||||||||
| a)
| Name | Essentra plc | |||||||||||||||||||||||||||||||
| b)
| LEI
| 5493007MOZNA03BVNE96 | |||||||||||||||||||||||||||||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||||||||||||||||||||||||||||||
| a)
| Description of the financial instrument, type of instrument | Ordinary 25p shares | |||||||||||||||||||||||||||||||
| | | ||||||||||||||||||||||||||||||||
| Identification code | GB00B0744359 | ||||||||||||||||||||||||||||||||
| | | ||||||||||||||||||||||||||||||||
| b)
| Nature of the transaction
| Transfer and sale of shares | |||||||||||||||||||||||||||||||
| c)
| Price(s) and volume(s) | |
| | | ||||||||||||||||||||||||||||
| d)
| Aggregated information | | |||||||||||||||||||||||||||||||
| | | ||||||||||||||||||||||||||||||||
| - Aggregated volume | As above | ||||||||||||||||||||||||||||||||
| - Price | | ||||||||||||||||||||||||||||||||
| | | ||||||||||||||||||||||||||||||||
| e)
| Date of the transaction
| 6 October 2025 | |||||||||||||||||||||||||||||||
| f)
| Place of the transaction | London Stock Exchange (XLON) | |||||||||||||||||||||||||||||||
*Essentra operates a dividend reinvestment scheme ("DRIP") and accordingly the following number of shares accumulated during the performance period and were included in the transaction.
| LTIP | 9,952 |
| DASB
| 9,280 |
For further enquiries, please contact
Essentra plc
Emma Reid
Company Secretary
T: + 44 (0) 1908 359100
6th October 2025
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.